Paper42903460PubMed
Pancreatic cancer cachexia: A systemic consequence of multi-organ interactions.
Xiao A and 7 others. Hlife, 2025.
Cite this record
ConductScience Library. Pancreatic cancer cachexia: A systemic consequence of multi-organ interactions. Papers, record 42903460. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42903460
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pancreatic cancer cachexia: A systemic consequence of multi-organ interactions.
- Journal
- Hlife
- Year
- 2025
- Publication types
- Journal Article, Review
- Revised in PubMed
- 2026-10-23
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References404
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21822537 | Evidence for cardiac atrophic remodeling in cancer-induced cachexia in mice. | Int J Oncol | 2011 | https://conductscience.org/library/papers/21822537 | PubMed |
| 2 | 24748626 | Prevalence of malnutrition and current use of nutrition support in patients with cancer. | JPEN J Parenter Enteral Nutr | 2014 | https://conductscience.org/library/papers/24748626 | PubMed |
| 3 | 17213191 | Skeletal muscle atrophy, a link between depression of protein synthesis and increase in degradation. | J Biol Chem | 2007 | https://conductscience.org/library/papers/17213191 | PubMed |
| 4 | 32039522 | Microglia in the hypothalamus respond to tumor-derived factors and are protective against cachexia during pancreatic cancer. | Glia | 2020 | https://conductscience.org/library/papers/32039522 | PubMed |
| 5 | 28261113 | Validation of the CAchexia SCOre (CASCO). Staging Cancer Patients: The Use of miniCASCO as a Simplified Tool. | Front Physiol | 2017 | https://conductscience.org/library/papers/28261113 | PubMed |
| 6 | 33396237 | Association between Growth Differentiation Factor-15 (GDF-15) Serum Levels, Anorexia and Low Muscle Mass among Cancer Patients. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/33396237 | PubMed |
| 7 | 26172047 | TGF-β Blockade Reduces Mortality and Metabolic Changes in a Validated Murine Model of Pancreatic Cancer Cachexia. | PLoS One | 2015 | https://conductscience.org/library/papers/26172047 | PubMed |
| 8 | 28730707 | Establishment and characterization of a novel murine model of pancreatic cancer cachexia. | J Cachexia Sarcopenia Muscle | 2017 | https://conductscience.org/library/papers/28730707 | PubMed |
| 9 | 11875710 | Role of beta3-adrenergic receptors in the action of a tumour lipid mobilizing factor. | Br J Cancer | 2002 | https://conductscience.org/library/papers/11875710 | PubMed |
| 10 | 23771498 | Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases. | Arch Pharm Res | 2013 | https://conductscience.org/library/papers/23771498 | PubMed |
| 11 | 7515956 | Do the differences between the amino acid compositions of acute-phase and muscle proteins have a bearing on nitrogen loss in traumatic states? | J Nutr | 1994 | https://conductscience.org/library/papers/7515956 | PubMed |
| 12 | 37006254 | Lipocalin-2 and neutrophil activation in pancreatic cancer cachexia. | Front Immunol | 2023 | https://conductscience.org/library/papers/37006254 | PubMed |
| 13 | 29140787 | TGF-β requires the activation of canonical and non-canonical signalling pathways to induce skeletal muscle atrophy. | Biol Chem | 2018 | https://conductscience.org/library/papers/29140787 | PubMed |
| 14 | 22761662 | Restoring specific lactobacilli levels decreases inflammation and muscle atrophy markers in an acute leukemia mouse model. | PLoS One | 2012 | https://conductscience.org/library/papers/22761662 | PubMed |
| 15 | 35893867 | Reducing White Adipose Tissue Browning Using p38α MAPK Inhibitors Ameliorates Cancer-Associated Cachexia as Assessed by Magnetic Resonance Imaging. | Nutrients | 2022 | https://conductscience.org/library/papers/35893867 | PubMed |
| 16 | 36165100 | A preponderance of gastrointestinal cancer patients transition into cachexia syndrome. | J Cachexia Sarcopenia Muscle | 2022 | https://conductscience.org/library/papers/36165100 | PubMed |
| 17 | 11754863 | Postoperative pancreatic exocrine function influences body weight maintenance after pylorus-preserving pancreatoduodenectomy. | Am J Surg | 2001 | https://conductscience.org/library/papers/11754863 | PubMed |
| 18 | 34094711 | Cancer-derived exosome miRNAs induce skeletal muscle wasting by Bcl-2-mediated apoptosis in colon cancer cachexia. | Mol Ther Nucleic Acids | 2021 | https://conductscience.org/library/papers/34094711 | PubMed |
| 19 | 25043053 | Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia. | Nature | 2014 | https://conductscience.org/library/papers/25043053 | PubMed |
| 20 | 31390573 | Modeling Human Cancer-induced Cachexia. | Cell Rep | 2019 | https://conductscience.org/library/papers/31390573 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42926650 | Behavioral dysfunction but not wasting in cancer cachexia is driven by altered tryptophan metabolism. | bioRxiv | 2026 | https://conductscience.org/library/papers/42926650 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42903460
GET https://conductscience.org/api/papers/v1/42903460/references?page=2